[go: up one dir, main page]

IT8520273A0 - PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPIETIC ADAPTIVITY. - Google Patents

PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPIETIC ADAPTIVITY.

Info

Publication number
IT8520273A0
IT8520273A0 IT8520273A IT2027385A IT8520273A0 IT 8520273 A0 IT8520273 A0 IT 8520273A0 IT 8520273 A IT8520273 A IT 8520273A IT 2027385 A IT2027385 A IT 2027385A IT 8520273 A0 IT8520273 A0 IT 8520273A0
Authority
IT
Italy
Prior art keywords
antigalactopietic
adaptivity
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IT8520273A
Other languages
Italian (it)
Other versions
IT1215261B (en
Inventor
Stefano Poli
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT8520273A priority Critical patent/IT1215261B/en
Publication of IT8520273A0 publication Critical patent/IT8520273A0/en
Priority to DE19853525388 priority patent/DE3525388A1/en
Priority to JP61078050A priority patent/JPS61280430A/en
Priority to FR8604864A priority patent/FR2579894A1/fr
Priority to GB08608310A priority patent/GB2173699A/en
Application granted granted Critical
Publication of IT1215261B publication Critical patent/IT1215261B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT8520273A 1985-04-05 1985-04-05 PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY. IT1215261B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT8520273A IT1215261B (en) 1985-04-05 1985-04-05 PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.
DE19853525388 DE3525388A1 (en) 1985-04-05 1985-07-16 USE OF HYDROGENATED ERGOT ALKALOIDS FOR TREATING PUERPERAL GALACTORRHOE
JP61078050A JPS61280430A (en) 1985-04-05 1986-04-04 Antilactic medicinal composition
FR8604864A FR2579894A1 (en) 1985-04-05 1986-04-04
GB08608310A GB2173699A (en) 1985-04-05 1986-04-04 Pharmaceutical compositions with antilactational activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8520273A IT1215261B (en) 1985-04-05 1985-04-05 PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.

Publications (2)

Publication Number Publication Date
IT8520273A0 true IT8520273A0 (en) 1985-04-05
IT1215261B IT1215261B (en) 1990-01-31

Family

ID=11165332

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8520273A IT1215261B (en) 1985-04-05 1985-04-05 PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.

Country Status (5)

Country Link
JP (1) JPS61280430A (en)
DE (1) DE3525388A1 (en)
FR (1) FR2579894A1 (en)
GB (1) GB2173699A (en)
IT (1) IT1215261B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2635599A (en) * 1999-03-17 2000-10-04 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
DE102007014947B4 (en) * 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilized aqueous solutions of ergoline compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2311071A1 (en) * 1973-03-06 1974-09-12 Sandoz Ag Use of prolactin inhibitors - for treatment of nephropathies and chronic nephritis
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3922347A (en) * 1974-12-19 1975-11-25 Lilly Co Eli Method of inhibiting prolactin secretion with 8-acylaminoergolenes
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
PH15001A (en) * 1977-07-25 1982-03-22 Sandoz Ag Prolactin secretion inhibitors

Also Published As

Publication number Publication date
IT1215261B (en) 1990-01-31
DE3525388A1 (en) 1986-10-09
JPS61280430A (en) 1986-12-11
GB8608310D0 (en) 1986-05-08
DE3525388C2 (en) 1988-04-14
GB2173699A (en) 1986-10-22
FR2579894A1 (en) 1986-10-10

Similar Documents

Publication Publication Date Title
IT8522800A0 (en) EFFEVERSCENT COMPOSITION ANALGESIC ADAPTIVITY.
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
FI862479L (en) ORAL PHARMACEUTICAL COMPOSITION.
IT8323205A0 (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND/OR ANALGESIC ADAPTIVITY, NON-ULCEROGENIC.
IT8820386A0 (en) OROSOLUBLE PHARMACEUTICAL COMPOSITIONS CONTAINING ACETYLCISTEINE.
DE3682083D1 (en) PHARMACEUTICAL COMPOSITIONS.
FI872733L (en) PHARMACEUTICAL COMPOSITIONS.
FI872313L (en) PHARMACEUTICAL COMPOSITIONS.
IT8521498A0 (en) ISOINDOLINYL-ALKYL-PIPERAZINE PHARMACEUTICAL ADAPTIVITY.
IT1213453B (en) PHARMACEUTICAL COMPOSITION.
DE3674040D1 (en) PHARMACEUTICAL COMPOSITIONS.
IT8319958A0 (en) PHARMACEUTICAL COMPOSITIONS ANTINEOPLASTIC ADAPTIVITY.
IT8520234A0 (en) PHARMACEUTICAL COMPOSITION POSTMINERGIC ADAPTIVITY.
IT8619162A0 (en) ACYLAMINOALCANOYL COMPOUNDS PHARMACEUTICAL ADAPTIVITY.
MX11584A (en) PHARMACEUTICAL COMPOSITIONS
DE3669656D1 (en) MEDICINAL COMPOSITIONS CONTAINING AZANAPHTHALENE.
IT8322427A0 (en) PHARMACEUTICAL COMPOSITIONS ANTIBIOTIC-IMMUNOSTIMULANT ADAPTIVITY.
IT1216814B (en) PHARMACEUTICAL COMPOSITIONS
IT8520273A0 (en) PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPIETIC ADAPTIVITY.
IT8520591A0 (en) PHARMACEUTICAL FORMULATION.
IT1203737B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING 3-AMINOPROPOSSI-INDOLI
FR2583416B1 (en) COMPOSITION OF AMINOBENZYLAMINES.
IT8220251A0 (en) PHARMACEUTICAL COMPOSITION IMMUNOMODULATOR ADAPTIVITY.
IT8621925A0 (en) PHARMACEUTICAL COMPOSITIONS ANTINEOPLASTIC ADAPTIVITY.
IT8622051A0 (en) PHARMACEUTICAL COMPOSITIONS HEALING ADAPTIVITY.